Economic Observation Network Shandong Xinhua Pharmaceutical Co., Ltd. (00719. HK) recently disclosed arrangements related to the executive reduction window and the extraordinary shareholders' meeting, involving the reduction plan of the board secretary and the appointment and review of executive directors.

Related Events
From November 5th to February 4th, 2027, it is the window period for the reduction of holdings requested by the Secretary of the Board of Directors, Cao Changqiu. The proposed reduction of holdings will not exceed 83300 shares (accounting for 0.012% of the total share capital), which is a very small proportion and has more symbolic meaning than substance. However, it will temporarily suppress emotions 。

Around November 10th, the company will hold an extraordinary shareholders' meeting to consider the proposal to appoint Liu Weimin as the executive director This is a management replacement action, focusing on the subsequent strategic direction statement.

The above content is based on publicly available information and does not constitute investment advice.